4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-020874
Director sold 41,666 shares at an average $156.98 ($6,540,905)
- Director acquired 41,666 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hindson Benjamin J. · Director
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-12 | Exercise or conversion : show line 1 in the form | +36,364 | $0.88 | $32,000 | 73,000 | D |
| 2021-03-12 | Exercise or conversion : show line 2 in the form | +5,302 | $1.07 | $5,673 | 78,302 | D |
| 2021-03-12 | Sale : show line 3 in the form | −6,023 | $154.56 | $930,887 | 72,279 | D |
| 2021-03-12 | Sale : show line 4 in the form | −8,074 | $155.54 | $1,255,815 | 64,205 | D |
| 2021-03-12 | Sale : show line 5 in the form | −8,189 | $156.45 | $1,281,143 | 56,016 | D |
| 2021-03-12 | Sale : show line 6 in the form | −5,845 | $157.48 | $920,452 | 50,171 | D |
| 2021-03-12 | Sale : show line 7 in the form | −6,368 | $158.64 | $1,010,223 | 43,803 | D |
| 2021-03-12 | Sale : show line 8 in the form | −7,167 | $159.40 | $1,142,386 | 36,636 | D |
| Open-market sales · 41,666 sh · avg $156.98 · $6,540,905 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-12 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −36,364 | $0.88 | 2025-10-27 | 36,364 | 0 | D |
| 2021-03-12 | Exercise or conversion : show line 10 in the form Stock Option (right to buy) | −5,302 | $1.07 | 2026-11-18 | 5,302 | 119,698 | D |
Loading xslF345X03/doc4.xml…